LABP Annual Cash & Cash Equivalents
$37.50 M
+$859.00 K+2.34%
31 December 2023
Summary:
As of February 2, 2025, LABP annual cash & cash equivalents is $37.50 million, with the most recent change of +$859.00 thousand (+2.34%) on December 31, 2023. During the last 3 years, it has risen by +$35.08 million (+1452.11%).LABP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LABP Quarterly Cash And Cash Equivalents
$29.00 M
-$8.49 M-22.65%
31 March 2024
Summary:
As of February 2, 2025, LABP quarterly cash and cash equivalents is $29.00 million, with the most recent change of -$8.49 million (-22.65%) on March 31, 2024. Over the past year, it has dropped by -$13.40 million (-31.61%).LABP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LABP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.3% | -31.6% |
| 3 y3 years | +1452.1% | +238.4% |
| 5 y5 years | +10000.0% | +195.7% |
LABP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -35.9% |
Landos Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $29.00 M(-22.7%) |
| Dec 2023 | $37.50 M(+2.3%) | $37.50 M(-11.6%) |
| Sept 2023 | - | $42.41 M(-3.7%) |
| June 2023 | - | $44.05 M(-2.6%) |
| Mar 2023 | - | $45.24 M(+23.5%) |
| Dec 2022 | $36.64 M | $36.64 M(+26.9%) |
| Sept 2022 | - | $28.88 M(+50.1%) |
| June 2022 | - | $19.24 M(+70.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $11.29 M(+35.9%) |
| Dec 2021 | $8.30 M(+243.8%) | $8.30 M(-53.6%) |
| Sept 2021 | - | $17.89 M(-4.2%) |
| June 2021 | - | $18.69 M(+118.0%) |
| Mar 2021 | - | $8.57 M(+254.8%) |
| Dec 2020 | $2.42 M(-75.4%) | $2.42 M(-2.5%) |
| Sept 2020 | - | $2.48 M(-74.7%) |
| Dec 2019 | $9.81 M(+2632.0%) | $9.81 M |
| Dec 2018 | $359.00 K | - |
FAQ
- What is Landos Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Landos Biopharma?
- What is Landos Biopharma annual cash & cash equivalents year-on-year change?
- What is Landos Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Landos Biopharma?
- What is Landos Biopharma quarterly cash and cash equivalents year-on-year change?
What is Landos Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of LABP is $37.50 M
What is the all time high annual cash & cash equivalents for Landos Biopharma?
Landos Biopharma all-time high annual cash & cash equivalents is $37.50 M
What is Landos Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, LABP annual cash & cash equivalents has changed by +$859.00 K (+2.34%)
What is Landos Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LABP is $29.00 M
What is the all time high quarterly cash and cash equivalents for Landos Biopharma?
Landos Biopharma all-time high quarterly cash and cash equivalents is $45.24 M
What is Landos Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, LABP quarterly cash and cash equivalents has changed by -$13.40 M (-31.61%)